LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 18

Search options

  1. Article: Holocord syrinx presenting with foot drop.

    Henderson, Duncan / Alix, James J P / Sinha, Saurabh

    Journal of surgical case reports

    2019  Volume 2019, Issue 4, Page(s) rjz082

    Abstract: We present an unusual presentation of holocord syrinx. A 4-year-old boy presenting a 2-week history of right sided foot drop. An MRI revealed a holocord secondary to a chiari one malformation. He successfully underwent a craniocervical decompression. ... ...

    Abstract We present an unusual presentation of holocord syrinx. A 4-year-old boy presenting a 2-week history of right sided foot drop. An MRI revealed a holocord secondary to a chiari one malformation. He successfully underwent a craniocervical decompression. Post operatively the syrinx decreased in size and his foot drop completely resolved.
    Language English
    Publishing date 2019-04-12
    Publishing country England
    Document type Case Reports
    ISSN 2042-8812
    ISSN 2042-8812
    DOI 10.1093/jscr/rjz082
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Understanding the Mothers of Children with Spina Bifida and Hydrocephalus in Tanzania.

    Henderson, Duncan / Ndossi, Maxigama / Majige, Rebeca / Sued, Mwanaabas / Shabani, Hamissi

    World neurosurgery

    2020  Volume 142, Page(s) e331–e336

    Abstract: Objective: To identify if there are cultural, medical, educational, economic, nutritional and geographic barriers to the prevention and treatment of spina bifida and hydrocephalus.: Methods: The mothers of infants with spina bifida and hydrocephalus ... ...

    Abstract Objective: To identify if there are cultural, medical, educational, economic, nutritional and geographic barriers to the prevention and treatment of spina bifida and hydrocephalus.
    Methods: The mothers of infants with spina bifida and hydrocephalus admitted to Muhimbilli Orthopaedic Institute, Dar Es Salaam, Tanzania, between 2013 and 2014 were asked to complete a questionnaire. A total of 299 infants were identified: 65 with myelomeningoceles, 19 with encephaloceles, and 215 with isolated hydrocephalus. The questionnaire was completed by 294 of the mothers.
    Results: There was a high variation in the geographic origin of the mothers. Approximately 85% traveled from outside of Dar Es Salaam. The mean age was 29 (15-45) years old with a parity of 3 (1-10). The rates of consanguinity, obesity, antiepileptic medication, HIV seropositivity, and family history were 2%, 13%, 0%, 2%, and 2%, respectively. A maize-based diet was found in 84%, and only 3% of woman took folic acid supplementation, despite 61% of mothers stating that they wished to conceive another baby. Unemployment was high (77%), a low level of education was common (76% not attended any school or obtaining a primary level only), and 20% were single mothers. Hospital only was the preferred method of treatment for 94% of the mothers, and 85% of the babies were born in a hospital.
    Conclusions: Our study highlights some of the cultural, educational, geographic, nutritional, and economic difficulties in the prevention and management of spina bifida and hydrocephalus in Tanzania.
    MeSH term(s) Adolescent ; Adult ; Anticonvulsants/therapeutic use ; Birth Setting/statistics & numerical data ; Consanguinity ; Diet/statistics & numerical data ; Dietary Supplements ; Educational Status ; Encephalocele/epidemiology ; Encephalocele/prevention & control ; Encephalocele/surgery ; Female ; Folic Acid/therapeutic use ; Geography ; HIV Infections/epidemiology ; Health Knowledge, Attitudes, Practice ; Health Services Accessibility ; Hospitals ; Humans ; Hydrocephalus/epidemiology ; Hydrocephalus/prevention & control ; Hydrocephalus/surgery ; Kwashiorkor/epidemiology ; Meningomyelocele/epidemiology ; Meningomyelocele/prevention & control ; Meningomyelocele/surgery ; Middle Aged ; Mothers ; Obesity, Maternal/epidemiology ; Pregnancy ; Pregnancy Complications, Infectious/epidemiology ; Protein-Energy Malnutrition/epidemiology ; Qualitative Research ; Spinal Dysraphism/epidemiology ; Spinal Dysraphism/prevention & control ; Spinal Dysraphism/surgery ; Surveys and Questionnaires ; Tanzania/epidemiology ; Unemployment/statistics & numerical data ; Young Adult ; Zea mays
    Chemical Substances Anticonvulsants ; Folic Acid (935E97BOY8)
    Language English
    Publishing date 2020-07-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2534351-8
    ISSN 1878-8769 ; 1878-8750
    ISSN (online) 1878-8769
    ISSN 1878-8750
    DOI 10.1016/j.wneu.2020.06.224
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: ETV for successful treatment of holocord syrinx with hydrocephalus: a case report.

    Rose, Louis / Aldridge, William / Henderson, Duncan / Cox, Miriam / Sinha, Saurabh

    British journal of neurosurgery

    2020  Volume 35, Issue 1, Page(s) 7–10

    Abstract: Aim: to present evidence for the use of endoscopic third ventriculostomy (ETV) in the treatment of holocord syrinx.: Methods: ETV has been used in the treatment of obstructive hydrocephalus and syringomyelia secondary to Chiari 1 malformation. ... ...

    Abstract Aim: to present evidence for the use of endoscopic third ventriculostomy (ETV) in the treatment of holocord syrinx.
    Methods: ETV has been used in the treatment of obstructive hydrocephalus and syringomyelia secondary to Chiari 1 malformation. However, there have been no reports of ETV being utilised in the management of a holocord. We report a case of an 18 year old male with a symptomatic holocord syrinx who was successfully treated via ETV.
    Results: neurological improvement was noted both immediately and at follow up following ETV.
    Conclusion: ETV may represent a viable treatment option for holocord syrinx in some population groups.
    MeSH term(s) Adolescent ; Arnold-Chiari Malformation/complications ; Arnold-Chiari Malformation/diagnostic imaging ; Arnold-Chiari Malformation/surgery ; Humans ; Hydrocephalus/diagnostic imaging ; Hydrocephalus/surgery ; Male ; Neuroendoscopy ; Syringomyelia/complications ; Syringomyelia/diagnostic imaging ; Syringomyelia/surgery ; Third Ventricle/diagnostic imaging ; Third Ventricle/surgery ; Treatment Outcome ; Ventriculostomy
    Language English
    Publishing date 2020-01-29
    Publishing country England
    Document type Case Reports ; Journal Article
    ZDB-ID 639029-8
    ISSN 1360-046X ; 0268-8697
    ISSN (online) 1360-046X
    ISSN 0268-8697
    DOI 10.1080/02688697.2020.1718603
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: The Sensor Reservoir-does it change management?

    Bjornson, Anna / Henderson, Duncan / Lawrence, Esther / McMullan, John / Ushewokunze, Shungu

    Acta neurochirurgica

    2021  Volume 163, Issue 4, Page(s) 1087–1095

    Abstract: Background: The Miethke Sensor Reservoir sits within a ventriculoperitoneal shunt system to give a reading of the pressure within the shunt. This information can guide the management of hydrocephalus patients who present frequently with headaches.: ... ...

    Abstract Background: The Miethke Sensor Reservoir sits within a ventriculoperitoneal shunt system to give a reading of the pressure within the shunt. This information can guide the management of hydrocephalus patients who present frequently with headaches.
    Methods: We reviewed a cohort of 12 patients who underwent implantation of a Sensor Reservoir to assess how the management of their symptoms changed over a 4-year period.
    Results: When comparing the group before the Sensor Reservoir and after the Sensor Reservoir insertion, there was a 75% reduction in number of CT head scans (P<0.05), 100% reduction in episodes of ICP monitoring (P<0.05), 55% reduction in number of X-ray shunt series, and a 50% reduction in acute presentation to hospital with shunt-related symptoms. The number of clinic attendances increased by 44%. In addition, cost analysis showed a saving of £6952 per patients over the 2-year period following Sensor Reservoir insertion as a result of reduced admissions and investigations. Complications were seen in 3 patients-two patients developed shunt-related infections, and 1 patient underwent shunt revision due to a proximal shunt obstruction. Seventy-five percent of patients showed an improvement in their symptoms at the end of the 4-year period.
    Conclusion: Implantation of a Sensor Reservoir in shunt patients with chronic headaches can reduce the number of investigations and hospital admissions and guide management resulting in a clinical improvement.
    MeSH term(s) Cohort Studies ; Female ; Headache/etiology ; Humans ; Hydrocephalus/surgery ; Intracranial Pressure ; Male ; Monitoring, Physiologic/adverse effects ; Monitoring, Physiologic/instrumentation ; Monitoring, Physiologic/methods ; Retrospective Studies ; Ventriculoperitoneal Shunt/adverse effects ; Ventriculoperitoneal Shunt/instrumentation ; Ventriculoperitoneal Shunt/methods
    Language English
    Publishing date 2021-02-15
    Publishing country Austria
    Document type Evaluation Study ; Journal Article
    ZDB-ID 80010-7
    ISSN 0942-0940 ; 0001-6268
    ISSN (online) 0942-0940
    ISSN 0001-6268
    DOI 10.1007/s00701-021-04729-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The ventriculo-cholecystic shunt: does CSF volume matter?

    Henderson, Duncan / Budu, Alexandru / Horridge, Michelle / Jesurasa, Anthony / Sinha, Saurabh / Ushewokunze, Shungu / Fisher, Ross

    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery

    2019  Volume 35, Issue 9, Page(s) 1557–1560

    Abstract: Introduction: The management of hydrocephalus in paediatric patients where the peritoneum has failed can be challenging. One option is to perform a ventriculo-cholecystic shunt. However, little is known about the capacity of the gall bladder to ... ...

    Abstract Introduction: The management of hydrocephalus in paediatric patients where the peritoneum has failed can be challenging. One option is to perform a ventriculo-cholecystic shunt. However, little is known about the capacity of the gall bladder to accommodate cerebrospinal fluid (CSF).
    Methods: A retrospective case series was performed to include all paediatric patients who received a ventriculo-cholecystic shunt at a single centre, Sheffield Children's Hospital.
    Results: We identified three patients who had a ventriculo-cholecystic shunt inserted. The shunt survived past 1 year in two patients, who had pre-operative external ventricular drain (EVD) outputs of 8 and 10 ml/h respectively. One patient shunt failed at day four post-op due to distal dysfunction, his pre-operative EVD was over 30 ml/h.
    Conclusions: When considering a patient for a ventriculo-cholecystic shunt, caution should be taken if a high CSF output is known, for example, as per an EVD measurement.
    MeSH term(s) Cerebrospinal Fluid Shunts ; Child ; Child, Preschool ; Gallbladder/surgery ; Humans ; Hydrocephalus/surgery ; Infant ; Infant, Newborn ; Male ; Retrospective Studies ; Treatment Outcome
    Language English
    Publishing date 2019-07-27
    Publishing country Germany
    Document type Case Reports ; Journal Article
    ZDB-ID 605988-0
    ISSN 1433-0350 ; 0302-2803 ; 0256-7040
    ISSN (online) 1433-0350
    ISSN 0302-2803 ; 0256-7040
    DOI 10.1007/s00381-019-04317-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Prognostic factors following resection of intracranial metastases.

    Henderson, Duncan / Zafar, Arif / Bjornson, Anna / Razak, Adam / Achawal, Shailendra / Danciut, Mihai / Smith, Aubrey / O'Reilly, Gerry / Rajaraman, Chittoor / Bahl, Anuj

    Surgical neurology international

    2022  Volume 13, Page(s) 219

    Abstract: Background: The aim of this study was to identify prognostic factors associated with resection of intracranial metastases.: Methods: A retrospective case series including patients who underwent resection of cranial metastases from March 2014 to April ...

    Abstract Background: The aim of this study was to identify prognostic factors associated with resection of intracranial metastases.
    Methods: A retrospective case series including patients who underwent resection of cranial metastases from March 2014 to April 2021 at a single center. This identified 112 patients who underwent 124 resections. The median age was 65 years old (24-84) and the most frequent primary cancers were nonsmall cell lung cancer (56%), breast adenocarcinoma (13%), melanoma (6%), and colorectal adenocarcinoma (6%). Postoperative MRI with contrast was performed within 48 hours in 56% of patients and radiation treatment was administered in 41%. GraphPad Prism 9.2.0 was used for the survival analysis.
    Results: At the time of data collection, 23% were still alive with a median follow-up of 1070 days (68-2484). The 30- and 90-day, and 1- and 5-year overall survival rates were 93%, 83%, 35%, and 17%, respectively. The most common causes of death within 90 days were as follows: unknown (32%), systemic or intracranial disease progression (26%), and pneumonia (21%). Age and extent of neurosurgical resection were associated with overall survival (
    Conclusion: Age and extent of resection are potential predictors of long-term survival.
    Language English
    Publishing date 2022-05-27
    Publishing country United States
    Document type Journal Article
    ISSN 2229-5097
    ISSN 2229-5097
    DOI 10.25259/SNI_103_2022
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial).

    Hutchinson, Peter J / Edlmann, Ellie / Hanrahan, John G / Bulters, Diederik / Zolnourian, Ardalan / Holton, Patrick / Suttner, Nigel / Agyemang, Kevin / Thomson, Simon / Anderson, Ian A / Al-Tamimi, Yahia / Henderson, Duncan / Whitfield, Peter / Gherle, Monica / Brennan, Paul M / Allison, Annabel / Thelin, Eric P / Tarantino, Silvia / Pantaleo, Beatrice /
    Caldwell, Karen / Davis-Wilkie, Carol / Mee, Harry / Warburton, Elizabeth A / Barton, Garry / Chari, Aswin / Marcus, Hani J / Pyne, Sarah / King, Andrew T / Belli, Antonio / Myint, Phyo K / Wilkinson, Ian / Santarius, Thomas / Turner, Carole / Bond, Simon / Kolias, Angelos G

    Health technology assessment (Winchester, England)

    2024  Volume 28, Issue 12, Page(s) 1–122

    Abstract: Background: Chronic subdural haematoma is a collection of 'old blood' and its breakdown products in the subdural space and predominantly affects older people. Surgical evacuation remains the mainstay in the management of symptomatic cases.: Objective!# ...

    Abstract Background: Chronic subdural haematoma is a collection of 'old blood' and its breakdown products in the subdural space and predominantly affects older people. Surgical evacuation remains the mainstay in the management of symptomatic cases.
    Objective: The Dex-CSDH (DEXamethasone in Chronic SubDural Haematoma) randomised trial investigated the clinical effectiveness and cost-effectiveness of dexamethasone in patients with a symptomatic chronic subdural haematoma.
    Design: This was a parallel, superiority, multicentre, pragmatic, randomised controlled trial. Assigned treatment was administered in a double-blind fashion. Outcome assessors were also blinded to treatment allocation.
    Setting: Neurosurgical units in the UK.
    Participants: Eligible participants included adults (aged ≥ 18 years) admitted to a neurosurgical unit with a symptomatic chronic subdural haematoma confirmed on cranial imaging.
    Interventions: Participants were randomly assigned in a 1 : 1 allocation to a 2-week tapering course of dexamethasone or placebo alongside standard care.
    Main outcome measures: The primary outcome was the Modified Rankin Scale score at 6 months dichotomised to a favourable (score of 0-3) or an unfavourable (score of 4-6) outcome. Secondary outcomes included the Modified Rankin Scale score at discharge and 3 months; number of chronic subdural haematoma-related surgical interventions undertaken during the index and subsequent admissions; Barthel Index and EuroQol 5-Dimension 5-Level utility index score reported at discharge, 3 months and 6 months; Glasgow Coma Scale score reported at discharge and 6 months; mortality at 30 days and 6 months; length of stay; discharge destination; and adverse events. An economic evaluation was also undertaken, during which the net monetary benefit was estimated at a willingness-to-pay threshold of £20,000 per quality-adjusted life-year.
    Results: A total of 748 patients were included after randomisation: 375 were assigned to dexamethasone and 373 were assigned to placebo. The mean age of the patients was 74 years and 94% underwent evacuation of their chronic subdural haematoma during the trial period. A total of 680 patients (91%) had 6-month primary outcome data available for analysis: 339 in the placebo arm and 341 in the dexamethasone arm. On a modified intention-to-treat analysis of the full study population, there was an absolute reduction in the proportion of favourable outcomes of 6.4% (95% confidence interval 11.4% to 1.4%;
    Conclusions: This trial reports a higher rate of unfavourable outcomes at 6 months, and a higher rate of serious adverse events, in the dexamethasone arm than in the placebo arm. Dexamethasone was also not estimated to be cost-effective. Therefore, dexamethasone cannot be recommended for the treatment of chronic subdural haematoma in this population group.
    Future work and limitations: A total of 94% of individuals underwent surgery, meaning that this trial does not fully define the role of dexamethasone in conservatively managed haematomas, which is a potential area for future study.
    Trial registration: This trial is registered as ISRCTN80782810.
    Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 13/15/02) and is published in full in
    MeSH term(s) Adult ; Humans ; Aged ; Hematoma, Subdural, Chronic/drug therapy ; Hospitalization ; Cost-Benefit Analysis ; Double-Blind Method ; Dexamethasone/therapeutic use
    Chemical Substances Dexamethasone (7S5I7G3JQL)
    Language English
    Publishing date 2024-03-21
    Publishing country England
    Document type Randomized Controlled Trial ; Multicenter Study ; Journal Article
    ZDB-ID 2006765-3
    ISSN 2046-4924 ; 1366-5278
    ISSN (online) 2046-4924
    ISSN 1366-5278
    DOI 10.3310/XWZN4832
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Comparison of drug-eluting and bare-metal stents in patients with diabetes undergoing primary percutaneous coronary intervention: what is the evidence?

    Gollop, Nicholas D / Henderson, Duncan B H / Flather, Marcus D

    Interactive cardiovascular and thoracic surgery

    2013  Volume 18, Issue 1, Page(s) 112–116

    Abstract: A best evidence topic was written according to a structured protocol. The question addressed was, should the practising interventional cardiologist use drug-eluting stents (DESs) or bare-metal stents (BMSs) when undertaking primary percutaneous coronary ... ...

    Abstract A best evidence topic was written according to a structured protocol. The question addressed was, should the practising interventional cardiologist use drug-eluting stents (DESs) or bare-metal stents (BMSs) when undertaking primary percutaneous coronary intervention (PCI) in diabetic patients. The relevant outcomes that were used to determine the answer to this question included: in-stent restenosis, target vessel revascularization (TVR), mortality, myocardial infarction and in-stent thrombosis. The OVID Medline database was used to carry out the reported search for abstracts of relevant journal articles. Altogether 102 papers were found, of which 7 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. From the evidence available, we conclude that in-stent restenosis is less likely to occur over a follow-up of at least 6 months if a DES is used instead of a BMS. Furthermore, TVR is less likely to be required in diabetic patients who receive a DES in comparison with a BMS. Nevertheless, no significant difference in mortality between stents was detected by the studies reviewed. This included no difference in the incidence of cardiac and non-cardiac causes of death. There was evidence showing that DESs are associated with a decrease in the risk of myocardial infarction and, in particular, a decrease in non-Q-wave myocardial infarction. However, there was also conflicting evidence demonstrating no significant difference in the incidence of myocardial infarction between diabetic patients who had received a BMS or a DES. Moreover, the available evidence showed no significant difference in the risk of in-stent thrombosis for all DESs with the exception of Sirolimus eluting stents in which the evidence was not consistent. In summary, the available evidence supports the use of DESs over BMSs in diabetic patients undergoing primary PCI.
    MeSH term(s) Benchmarking ; Coronary Restenosis/etiology ; Coronary Thrombosis/etiology ; Diabetes Mellitus/diagnosis ; Diabetes Mellitus/mortality ; Drug-Eluting Stents ; Evidence-Based Medicine ; Female ; Humans ; Male ; Metals ; Middle Aged ; Myocardial Infarction/diagnosis ; Myocardial Infarction/mortality ; Myocardial Infarction/therapy ; Patient Selection ; Percutaneous Coronary Intervention/adverse effects ; Percutaneous Coronary Intervention/instrumentation ; Percutaneous Coronary Intervention/mortality ; Prosthesis Design ; Recurrence ; Risk Assessment ; Risk Factors ; Stents ; Treatment Outcome
    Chemical Substances Metals
    Language English
    Publishing date 2013-10-20
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2095298-3
    ISSN 1569-9285 ; 1569-9293
    ISSN (online) 1569-9285
    ISSN 1569-9293
    DOI 10.1093/icvts/ivt454
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Novel Colorimetric and Light Scatter Methods to Identify and Manage Peritoneal Dialysis-Associated Peritonitis at the Point-of-Care.

    Govindji-Bhatt, Nishal / Kennedy, Stephnie M / Barker, Michael G / Kell, Darren / Henderson, Duncan / Goddard, Nicholas / Garcia, Ana Yepes / Milner, Adam S / Willett, Tom / Griffiths, Ryan / Foster, Peter / Kilgallon, William / Cant, Rachel / Knight, Christopher G / Lewis, David / Corbett, Richard / Akbani, Habib / Woodrow, Graham / Sood, Bhrigu /
    Iyasere, Osasuyi / Davies, Simon / Qazi, Junaid / Vardhan, Anand / Gillis, Laura / Wilkie, Martin / Dobson, Curtis B

    Kidney international reports

    2023  Volume 9, Issue 3, Page(s) 589–600

    Abstract: Introduction: Peritoneal dialysis (PD)-related peritonitis (PDRP) is a common cause of transfer to hemodialysis, patient morbidity, and is a risk factor for mortality. Associated patient anxiety can deter selection of PD for renal replacement therapy. ... ...

    Abstract Introduction: Peritoneal dialysis (PD)-related peritonitis (PDRP) is a common cause of transfer to hemodialysis, patient morbidity, and is a risk factor for mortality. Associated patient anxiety can deter selection of PD for renal replacement therapy. Diagnosis relies on hospital laboratory tests; however, this might be achieved earlier if such information was available at the point-of-care (POC), thereby significantly improving outcomes. The presence of culturable microbes and the concentration of leukocytes in effluent both aid peritonitis diagnosis, as specified in the International Society for Peritoneal Dialysis (ISPD) diagnostic guidelines. Here, we report the development of 2 new methods providing such information in simple POC tests.
    Methods: One approach uses a tetrazolium-based chemical reporting system, primarily focused on detecting bacterial contamination and associated vancomycin-sensitivity. The second approach uses a novel forward light-scatter device (QuickCheck) to provide an instant quantitative cell count directly from PD patient effluent.
    Results: The tetrazolium approach detected and correctly distinguished laboratory isolates, taking 10 hours to provide non-quantitative results. We compared the technical performance of the light scatter leukocyte counting approach with spectrophotometry, hemocytometer counting and flow cytometry (Sysmex) using patient effluent samples. QuickCheck had high accuracy (94%) and was the most precise (coefficient of variation <4%), showing minimal bias, overall performing similarly to flow cytometry.
    Conclusion: These complementary new approaches provide a simple means to obtain information to assist diagnosis at the POC. The first provides antibiotic sensitivity following 10 hours incubation, whereas the second optical approach (QuickCheck), provides instant accurate total leukocyte count.
    Language English
    Publishing date 2023-12-30
    Publishing country United States
    Document type Journal Article
    ISSN 2468-0249
    ISSN (online) 2468-0249
    DOI 10.1016/j.ekir.2023.12.021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Giant vertebrobasilar aneurysm: a rare cause of central sleep apnoea.

    Haley, Mark Daniel / Henderson, Duncan Bruce Henry / Nowell, Mark / Adams, William M / Whitfield, Peter C

    British journal of neurosurgery

    2017  Volume 33, Issue 5, Page(s) 559–561

    Abstract: We report a case of central sleep apnoea (CSA) due to a giant vertebrobasilar aneurysm with brainstem compression. A flow diverter stent was deployed with coil embolization of the right vertebral artery distal to the posterior inferior cerebellar artery ( ...

    Abstract We report a case of central sleep apnoea (CSA) due to a giant vertebrobasilar aneurysm with brainstem compression. A flow diverter stent was deployed with coil embolization of the right vertebral artery distal to the posterior inferior cerebellar artery (PICA) to occlude the aneurysm. The patient's symptoms improved following therapy.
    MeSH term(s) Aged ; Blood Vessel Prosthesis ; Cerebellum/blood supply ; Continuous Positive Airway Pressure/methods ; Embolization, Therapeutic/methods ; Endovascular Procedures/methods ; Humans ; Intracranial Aneurysm/complications ; Intracranial Aneurysm/therapy ; Male ; Sleep Apnea, Central/etiology ; Sleep Apnea, Central/therapy ; Stents ; Vertebral Artery
    Language English
    Publishing date 2017-09-21
    Publishing country England
    Document type Case Reports ; Journal Article ; Video-Audio Media
    ZDB-ID 639029-8
    ISSN 1360-046X ; 0268-8697
    ISSN (online) 1360-046X
    ISSN 0268-8697
    DOI 10.1080/02688697.2017.1378800
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top